Background and Aim: The global prevalence of diabetes mellitus (DM) is rising continuously. Diabetic neuropathy being one of the most common complications has been well studied in lower limbs. Similarly it can also affect upper limbs progressively. But exact pathogenesis is not yet known. Comparatively there are very few studies showing relation between upper limb neuropathy and blood glucose levels. Hence, present study was conducted to study the relation between glycemic status & upper limb diabetic neuropathy in type 2 DM.
INTRODUCTION
The global prevalence of diabetes mellitus has grown from 4.7% (108 million) in 1980 to 8.5% (422 million) in 2014. Over the past decade, diabetes prevalence has risen faster in low-and middle-income countries than in high-income countries. Type 2 diabetes mellitus (DM) comprises the majority of diabetic people around the world. [1] Among all the complications, diabetic neuropathy is the most common and troublesome complication of diabetes mellitus leading to great morbidity and high healthcare cost. [2] It is one of the least understood complications, with reported prevalence ranging from less than 5% to approximately 60%. [3] Still, detailed studies are not available because of lack of uniform definition of diabetic neuropathy. In type 1 DM, distal polyneuropathy becomes symptomatic after chronic prolonged hyperglycemia for many years.
Conversely, patients with type 2 DM usually present with polyneuropathy within few years of poor glycemic control or even at the time diagnosis. However, the progress of neuropathy can be arrested by early detection and proper intervention. [4] It is a well known fact that diabetes increases the risk of lower limb neuropathy and amputation because of non-healing, infected foot ulcers. [5, 6] Subsequently or simultaneously diabetes can affect 
AIM & OBJECTIVES:
To assess and compare the conduction velocities and amplitudes of compound muscle action potentials of ulnar motor nerves and nerve action potentials of ulnar sensory nerves in normal healthy controls and patients with type 2DM of varying blood glucose levels.
METHODS

Study Design:
An observational analytical study was performed in type 2 DM male patients. All the patients were selected from diabetic OPD of the B. J. Govt. 
Medical
Inclusion and exclusion criteria:
Inclusion criteria: Normotensive patients taking regular oral hypoglycemic agents as advised by physician, non-smoker, non-alcoholic and nontobacco chewers were included in the study. and considered as significant.
RESULTS:
Difference in means of age, height, weight, body mass index was not statistically significant among three groups and hence these groups were comparable. ( Decrease in amplitude suggests axonal degeneration, whereas decrease in conduction velocity suggests demyelination. [8, 9, 13] Clinically, amplitude is more important, since most neuropathies are caused by damage to the nerve's axon. [14] In Also, ulnar SNAP was negatively correlated with Hb A1c levels, which was also statistically highly significant (p<0.001) (Figure 1 ).
This finding highlights the role of glycated haemoglobin in causation of diabetic neurapathy.
We also found that reduction in conduction velocity and amplitude of CMAP of ulnar motor nerve was statistically not significant in control group and in diabetic patients (Table 3 ).
In present study, we found that the reduction in means of amplitude of ulnar SNAP is statistically significant among three groups. But it is not significant in case of amplitude of ulnar Tkac I et al. [12] in their study recorded median motor and median sensory nerve amplitudes and conduction velocities. They found that raised glycated haemoglobin contributed greatly to reduction in sensory SNAP amplitudes.
We observed similar findings in present study. But they also found significant reduction in conduction velocity as well. We do observed slight reduction in conduction velocity, but it was not statistically significant. This difference in results could have appeared because mean age of duration of diabetes in their study was 12.5 years and in present study we have considered patients having diabetes duration between 0 to 5 years. Partanen J et al. [13] in their study on type 2 DM patients also found that, sensory amplitude of median nerves were lowered in long term poorly controlled diabetics indicating that chronic hyperglycemia had significant contribution in development of diabetic peripheral neuropathy and axonal degeneration predominates in upper limb neuropathy. These findings were confirmed in our study. Lee SS et al.
[18], Valensi P et al. [19] , DCCT research group [20] and Ugoya SO et al. [2] in their respective studies also highlighted the significance of hyperglycemia in causation of diabetic neuropathy.
On the contrary, Bagai K et al. [6] in their study observed that in type 2 DM patients, axonal injury was more common in legs while demyelinating injury was more common in arms. This difference need to be investigated in large scale study.
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